10x Genomics to Report Second Quarter Financial Results on August 11, 2020

Rhea-AI Summary

10x Genomics (TXG) will report its Q2 2020 financial results on August 11, 2020, after market close. A conference call will take place at 1:30 p.m. PT to discuss the results and company outlook. The webcast will be accessible via the company's website and archived for 45 days. 10x Genomics specializes in life science technology, offering integrated solutions that analyze biological systems. The company has been widely adopted by leading research institutions and pharmaceutical companies, with over 740 patents in its portfolio.

Positive

• Scheduled financial results report for Q2 2020 indicates transparency and active communication.
• Company's products are used by 97 of the top 100 global research institutions, indicating strong market presence.
• Patent portfolio of more than 740 patents demonstrates innovation and intellectual property strength.

Negative

• None.

PLEASANTON, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the second quarter 2020 after market close on Tuesday, August 11, 2020. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including 97 of the top 100 global research institutions and 19 of the top 20 global pharmaceutical companies, and have been cited in over 1,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 740 issued patents and patent applications.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts
Media:
media@10xgenomics.com
Investors:
investors@10xgenomics.com

 

FAQ

When will 10x Genomics report its Q2 2020 financial results?

10x Genomics will report its Q2 2020 financial results on August 11, 2020, after market close.

What time is the conference call for 10x Genomics Q2 2020 results?

The conference call for 10x Genomics Q2 2020 results will begin at 1:30 p.m. Pacific Time.

Where can I access the webcast for 10x Genomics financial results?

The webcast for 10x Genomics financial results can be accessed on their website in the 'Investors' section.

What are the recent achievements of 10x Genomics?

10x Genomics has a strong market presence with products adopted by 97 of the top 100 global research institutions and over 740 patents.